Absci (ABSI) Net Margin (2020 - 2026)

Absci's (ABSI) quarterly Net Margin came in at 13766.98% in Q1 2026, down 1153237.0% year-on-year from N/an in Q1 2025, and down 202.7% quarter-over-quarter from 4548.0% in Q4 2025.

Absci (ABSI) Net Margin (2020 - 2026) Analysis & Trends

Absci has disclosed Net Margin across 7 years of filings, most recently posting 13766.98% for Q1 2026.

  • Net Margin for Q1 2026 came in at 13766.98%, down 1153237.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6450.76% (down 421863.0% YoY), and the FY2025 annual result was 4113.68%, down 183962.0% from the prior year.
  • Net Margin came in at 13766.98% for Q1 2026 at Absci, down from 4548.0% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1150.65% in Q3 2022 to a low of 15959.84% in Q4 2022.
  • The 5-year median for Net Margin is 2956.18% (2023), against an average of 4983.37%.
  • Peak annual rise in Net Margin reached 2820022 bps in 2022, while the deepest fall reached 1225350 bps in 2022.
  • Absci's Net Margin stood at 15959.84% in 2022, then soared by 56 bps to 6965.98% in 2023, then surged by 37 bps to 4358.35% in 2024, then slipped by 4 bps to 4548.0% in 2025, then plunged by 203 bps to 13766.98% in 2026.
  • The last three Net Margin figures came in at 13766.98% (Q1 2026), 4548.0% (Q4 2025), and 7594.18% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - -13,766.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13,766.98%
Dec 31, 2025 -4,548.00%
Sep 30, 2025 -7,594.18%
Jun 30, 2025 -5,154.97%
Mar 31, 2025 -2,234.61%
Dec 31, 2024 -4,358.35%
Sep 30, 2024 -1,610.70%
Jun 30, 2024 -1,948.82%
Mar 31, 2024 -2,447.10%
Dec 31, 2023 -6,965.98%
Sep 30, 2023 -2,956.18%
Jun 30, 2023 -1,237.66%
Mar 31, 2023 -1,840.43%
Dec 31, 2022 -15,959.84%
Sep 30, 2022 -1,150.65%
Jun 30, 2022 -2,862.28%
Mar 31, 2022 -8,080.55%
Dec 31, 2021 -3,706.33%
Sep 30, 2021 -1,717.70%
Jun 30, 2021 -31,062.50%